Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pennington Allen Capital Partners is a private equity investment firm based in Tulsa, Oklahoma, that specialized in the acquisition and recapitalization of small to medium-sized businesses. Founded in 2003, the firm targeted companies in the manufacturing, distribution, and service sectors, particularly those located in the Southwest, Midwest, and Southeast United States. Within the healthcare sector, the firm is known for its majority investment in Knox Laboratory, a provider of drug testing and laboratory services. The firm's principals, W. Lane Pennington and Mark H. Allen, provided strategic and operational oversight to their portfolio companies, which also included Bliss Industries and ORS Nasco. During its active period, the firm participated in transactions with a total enterprise value exceeding $800 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pennington Allen Capital Partners.